CASCELLA ROBERT (CIK 1218713) reported 15 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy CLS (84 shares), Sell CLS (5 shares), Buy KRMD (3,571 shares), Buy STIM (36,250 shares), Buy MIR (7,383 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | CELESTICA INC (CLS) | Director | Buy | 84 | $0 |
| 2026-07-02 | CELESTICA INC (CLS) | Director | Sell | 5 | $1,716 |
| 2026-07-01 | KORU Medical Systems, Inc. (KRMD) | Director | Buy | 3,571 | $14,998 |
| 2026-05-29 | Neuronetics, Inc. (STIM) | Director | Buy | 36,250 | $0 |
| 2026-05-14 | Mirion Technologies, Inc. (MIR) | Director | Buy | 7,383 | $0 |
| 2026-04-02 | CELESTICA INC (CLS) | Director | Buy | 156 | $0 |
| 2026-04-02 | CELESTICA INC (CLS) | Director | Sell | 9 | $2,315 |
| 2026-01-02 | KORU Medical Systems, Inc. (KRMD) | Director | Buy | 2,581 | $14,996 |
| 2025-10-22 | Neuronetics, Inc. (STIM) | Director | Buy | 10,531 | $0 |
| 2025-10-02 | KORU Medical Systems, Inc. (KRMD) | Director | Buy | 3,916 | $14,998 |
| 2025-07-02 | KORU Medical Systems, Inc. (KRMD) | Director | Buy | 4,189 | $14,997 |
| 2025-05-27 | Neuronetics, Inc. (STIM) | Director | Buy | 36,250 | $0 |
| 2025-05-16 | Mirion Technologies, Inc. (MIR) | Director | Buy | 7,977 | $0 |
| 2025-04-02 | KORU Medical Systems, Inc. (KRMD) | Director | Buy | 5,870 | $15,027 |
| 2025-02-10 | Neuronetics, Inc. (STIM) | Director | Buy | 88,888 | $199,998 |
Source: SEC Form 4 filings · as of 2026-07-02